Wegovy and Injection site discoloration - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Wegovy?
Wegovy has active ingredients of semaglutide. It is used in weight loss. Currently, eHealthMe is studying from 2,629 Wegovy users.
What is Injection Site Discoloration?
Injection site discoloration is found to be associated with 1,076 drugs and 493 conditions by eHealthMe. Currently, we are studying 11,632 people who have Injection site discoloration.
Do you take Wegovy and have Injection site discoloration?Check whether Injection site discoloration is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Wegovy side effects by duration, gender and age:
- Wegovy side effects (2,629 reports)
Injection site discoloration treatments and more:
- Injection site discoloration (11,632 reports)
All the drugs that are associated with Injection site discoloration:
All the conditions that are associated with Injection site discoloration:
How the study uses the data?
The study uses data from the FDA. It is based on semaglutide (the active ingredients of Wegovy) and Wegovy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Biotin and Joint Injury - 2 seconds ago
- Plavix and Gingival Erythema - 4 seconds ago
- Phenytoin and Agranulocytosis - 6 seconds ago
- Mylotarg and Streptococcal Bacteraemia - 7 seconds ago
- Tresiba and Oedema Peripheral - 8 seconds ago
- Robaxin and Adverse Drug Reaction - 11 seconds ago
- Amphotericin B and Constipation - 11 seconds ago
- Methimazole and Psoriasis - 16 seconds ago
- Uniphyl and Hyperglycemia - 18 seconds ago
- Sertraline Hydrochloride and Paleness - 22 seconds ago